These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23162654)

  • 1. Evaluation of carboplatin dosing in non-small cell lung carcinoma patients using Calvert formula and Cockroft and Gault equation for glomerular filtration rate estimation.
    Bar-Sela G; Kaidar-Person O; Mari F; Assady S; Haim N
    Oncol Lett; 2012 Nov; 4(5):1072-1076. PubMed ID: 23162654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
    Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
    Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
    Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
    Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care.
    McLean L; Whittle JR; Graham J; Ismail H; Lichtenstein M; Hicks RJ; McNally O; Herschtal A; Rosenthal M; Rischin D; Hamilton A
    Gynecol Oncol; 2020 Jun; 157(3):793-798. PubMed ID: 32220419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
    Morrow A; Garland C; Yang F; De Luna M; Herrington JD
    J Oncol Pharm Pract; 2019 Oct; 25(7):1651-1657. PubMed ID: 30336729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimens.
    Nannan Panday VR; van Warmerdam LJ; Huizing MT; Ten Bokkel Huinink WW; Vermorken JB; Giaccone G; Veenhof CH; Schellens JH; Beijnen JH
    Clin Drug Investig; 1998; 15(4):327-35. PubMed ID: 18370488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.
    White-Koning M; Paludetto MN; Le Louedec F; Gladieff L; Chevreau C; Chatelut E; Puisset F
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):585-592. PubMed ID: 31915969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
    Graciano Vera N; Pino Villarreal L; Ureña Vargas J
    Chemotherapy; 2018; 63(3):137-142. PubMed ID: 29768260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
    Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors.
    Kaag D
    Lung Cancer; 2013 Jan; 79(1):54-8. PubMed ID: 23131495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.
    Samani A; Bennett R; Eremeishvili K; Kalofonou F; Whear S; Montes A; Kristeleit R; Krell J; McNeish I; Ghosh S; Tookman L
    ESMO Open; 2022 Apr; 7(2):100401. PubMed ID: 35227967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
    Herrington JD; Tran HT; Riggs MW
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):241-7. PubMed ID: 16133538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ; Poole SG; Rischin D; Webster LK
    Eur J Cancer; 2002 Jan; 38(1):44-51. PubMed ID: 11750838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
    Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin.
    van Warmerdam LJ; Rodenhuis S; ten Bokkel Huinink WW; Maes RA; Beijnen JH
    Cancer Chemother Pharmacol; 1996; 37(3):266-70. PubMed ID: 8529288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extension of the Calvert formula to patients with severe renal insufficiency.
    Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
    Holweger K; Lipp HP; Beijnen JH; Bokemeyer C; Hartmann JT
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.